KalVista Pharmaceuticals Announces Approval of EKTERLY® (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema
FRAMINGHAM, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the Ministry of Health,... Read more.
Walker & Dunlop Arranges $867 Million Financing Package for the Largest Single-Building, Office-to-Residential Conversion in the U.S.
BETHESDA, Md.–(BUSINESS WIRE)–Walker & Dunlop, Inc. announced today that it has arranged a $778.6 million construction loan to facilitate the office-to-residential... Read more.
Ennis, Inc. Reports Results for the Quarter Ended November 30, 2025 and Declares Quarterly Dividend
MIDLOTHIAN, Texas–(BUSINESS WIRE)–Ennis, Inc. (the “Company”), (NYSE: EBF), today reported financial results for the quarter ended November 30, 2025.... Read more.
Omdia: Global Cloud Infrastructure Spending Hits $102.6 Billion, up 25% in Q3 2025
LONDON–(BUSINESS WIRE)–#Cloud–According to new research from Omdia, global spending on cloud infrastructure services reached $102.6 billion in... Read more.
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch
TOKYO–(BUSINESS WIRE)–#axelspace–Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within... Read more.
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.
TOKYO–(BUSINESS WIRE)–#axelspace–Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within... Read more.
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease
CADEMPINO, Switzerland–(BUSINESS WIRE)–#ClinicalTrial—Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build... Read more.
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved... Read more.
KKR Launches European Rail Leasing Platform with Green Mobility Partners
Strategic partnership to scale newly established locomotive and train leasing company into a leading European rail leasing platform FRANKFURT, Germany–(BUSINESS... Read more.
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved... Read more.